Tissue Engineering Opens Door to Novel Type 1 Diabetes Therapy - Genetic Engineering & Biotechnology News


Genetic Engineering & Biotechnology News

Tissue Engineering Opens Door to Novel Type 1 Diabetes Therapy
Genetic Engineering & Biotechnology News
Investigators from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine say they have produced the first clinical results demonstrating that pancreatic islet cells transplanted within a tissue-engineered platform ...
Transplant of Insulin-Producing Cells Offers Hope Against Type 1 DiabetesLincoln Journal Star
DRI BioHub device helps woman achieve insulin independence in new type 1 diabetes trialDiabetes.co.uk

all 3 news articles »